• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1011917-040
Device Problems Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017); Activation Failure (3270)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 11/16/2022
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.(b)(4).
 
Event Description
It was reported that the procedure was to treat the left external iliac artery with low calcification and low tortuosity via cross over access from the right side.A non-abbott 6fr 45 cm sheath was placed and pre-dilatation was performed.The 8x40 mm absolute pro self expanding stent (ses) was deployed without resistance and the delivery system was then attempted to be removed.During removal there was resistance and some force was applied to remove the system and it was seen that the stent was still attached to the delivery system tip.During removal the distal part of the stent separated and was released in the primitive iliac artery.The delivery system was removed with the proximal portion of the stent still in the delivery system.The distal portion of the stent was left in the anatomy and secured to the vessel with a new stent.A non-abbott stent was used to treat the initial target lesion.There were no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported difficult to remove was unable to be replicated in a testing environment as it was based on operational circumstances.The reported material separation stent and the reported activation/deployment failure were unable to be replicated in a testing environment due to the condition of the returned device/stent not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Reportedly, during removal there was resistance and some force was applied to remove the system.It should be noted that the absolute pro.035 peripheral self-expanding stent system instructions for use (ifu) states: should unusual resistance be felt at any time during lesion or stricture access or delivery system removal, the introducer sheath / guiding catheter and stent system should be removed as a single unit.Applying excessive force to the stent delivery system can potentially result in loss or damage to the stent and delivery system components.Although resistance was noted during removal, the force applied during removal of the device seemed to be a reasonable clinical response to the difficulties.The investigation determined the reported/noted difficulties appear to be related to circumstances of the procedure as it is likely that during removal the delivery system tip inadvertently was caught with the deployed stent; thus resulting in the reported difficult to remove.Manipulation of the compromised device ultimately resulted in the reported stent material separation; thus resulting in the reported activation/deployment failure.Manipulation of the device likely resulted in the noted multiple distal sheath kinks/chatter marks.As reported, the distal portion of the stent was left in the anatomy and secured to the vessel with a new stent.The reported treatment(s) appear to be related to the operational context of the procedure as reportedly the distal portion of the stent was left in the anatomy and secured to the vessel with a new stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15946348
MDR Text Key305140256
Report Number2024168-2022-12426
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K072708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011917-040
Device Lot Number2081761
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6FR 45 CM SHEATH
Patient Outcome(s) Required Intervention;
-
-